STOKE THERAPEUTICS INC shareholders Q2 2023

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 100 filers reported holding STOKE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.8%.

STOKE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
BARCLAYS PLC 14,829$1570.00%
ROYAL BANK OF CANADA 2,959$32,0000.00%
VANGUARD GROUP INC 1,606,784$17,080,1140.00%
Swiss National Bank 43,300$460,2790.00%
CANADA LIFE ASSURANCE Co 2,968$320.00%
TD ASSET MANAGEMENT INC 26,186$278,3570.00%
VOYA INVESTMENT MANAGEMENT LLC 11,175$118,7900.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 26,662$283,4170.00%
UBS Group AG 23,081$245,3510.00%
ALLIANCEBERNSTEIN L.P. 41,320$439,2320.00%
PRINCIPAL FINANCIAL GROUP INC 11,388$121,0550.00%
Belvedere Trading LLC 1,600$17,0080.00%
Belvedere Trading LLC 2,500$26,5750.00%
Belvedere Trading LLC 15,783$167,7730.00%
BNP PARIBAS FINANCIAL MARKETS 7,305$77,6520.00%
OSAIC HOLDINGS, INC. 100$1,0620.00%
US BANCORP \DE\ 821$8,7270.00%
FRANKLIN RESOURCES INC 12,643$134,3950.00%
Parallel Advisors, LLC 57$6060.00%
BANK OF AMERICA CORP /DE/ 20,347$216,2890.00%
External links

This page lists STOKE THERAPEUTICS INC's shareholders in Q2 2023. To view STOKE THERAPEUTICS INC's shareholder history, click here.